EP Life Sciences Ltd. — Form D/A

EP Life Sciences Ltd. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2026-03-16. $52.8M was reported sold. Industry: Pooled Investment Fund.

Offering

Issuer

Officers, directors & promoters (16)

NameRoleLocation
Michael FierroRelated PersonNew York, NY
Kabir S KapoorRelated PersonNEW YORK, NY
Gregory LinkRelated PersonGeorge Town, Grand Cayman, E9
Marty PiccinichRelated PersonNew York, NY
Ralph WoodfordRelated PersonGrand Cayman, E9
Patrick JC ShawDirectorNew York, NY
Michael S FierroDirectorNew York, NY
Gregory S LinkDirectorGrand Cayman, E9
Ralph S WoodfordDirectorGrand Cayman, E9
Kabir S KapoorDirectorNEW YORK, NY
Marty S PiccinichDirectorNEW YORK, NY
Gregory W LinkDirectorGrand Cayman, E9
Ralph W WoodfordDirectorGrand Cayman, E9
Kurt JC DudasDirectorNew York, NY
Steven W DavdsonDirectorNEW YORK, NY
Kurt S DudasDirectorNEW YORK, NY

Other filings by this issuer (8)

FiledFormOfferingSold
2025-03-21D/A$46.3M
2024-03-26D/A$46.1M
2023-03-27D/A$46.9M
2022-03-28D/A$48.5M
2021-06-08D/A$44.6M
2020-06-08D/A$31.3M
2019-06-17D/A$29.1M
2018-06-28D

More